Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Nitish Kumar, Bharat Khurana & Daisy Arora. (2023) Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions. Pharmaceutical Development and Technology 0:0, pages 1-16.
Read now
Read now
Jie Li, Jiaqian Zhao, Tiantian Tan, Mengmeng Liu, Zhaowu Zeng, Yiying Zeng, Lele Zhang, Chaomei Fu, Dajing Chen & Tian Xie. (2020) Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review. International Journal of Nanomedicine 15, pages 2563-2582.
Read now
Read now
Rania M. Hathout, Sherweit H. El-Ahmady & AbdelKader A. Metwally. (2018) Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study. Natural Product Research 32:24, pages 2873-2881.
Read now
Read now
Amrish Kumar & Sunil Kumar Jain. (2017) Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method. Artificial Cells, Nanomedicine, and Biotechnology 45:3, pages 515-521.
Read now
Read now
Juilee A. Kulkarni & Amelia M. Avachat. (2017) Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability. Drug Development and Industrial Pharmacy 43:2, pages 234-245.
Read now
Read now
Guangxiu Deng & Lan Jin. (2017) The effects of vasoactive intestinal peptide in neurodegenerative disorders. Neurological Research 39:1, pages 65-72.
Read now
Read now
Adryana Clementino, Mellissa Batger, Gabriela Garrastazu, Michele Pozzoli, Elena Del Favero, Valeria Rondelli, Bianca Gutfilen, Thiago Barboza, Maria B Sukkar, Sergio A L Souza, Laura Cantù & Fabio Sonvico. (2016) The nasal delivery of nanoencapsulated statins – an approach for brain delivery. International Journal of Nanomedicine 11, pages 6575-6590.
Read now
Read now
Débora B Vieira & Lionel F Gamarra. (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 11, pages 5381-5414.
Read now
Read now
Surjyanarayan Mandal, Snigdha Das Mandal, Krishna Chuttani, Krutika K Sawant & Bharat Bhushan Subudhi. (2016) Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model. Drug Development and Industrial Pharmacy 42:8, pages 1340-1350.
Read now
Read now
P. R. Ravi, N. Aditya, S. Patil & L. Cherian. (2015) Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization. Drug Delivery 22:7, pages 903-910.
Read now
Read now
Sylvain Martel. (2015) Learning from our failures in blood–brain permeability: what can be done for new drug discovery?. Expert Opinion on Drug Discovery 10:3, pages 207-211.
Read now
Read now
Sumit Sharma, Shikha Lohan & R. S. R. Murthy. (2014) Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug Development and Industrial Pharmacy 40:7, pages 869-878.
Read now
Read now
Xingguo Zhang, Lin Liu, Guobao Chai, Xiangyi Zhang & Fanzhu Li. (2013) Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Drug Development and Industrial Pharmacy 39:11, pages 1618-1624.
Read now
Read now
Sermin Genc, Zeynep Zadeoglulari, Meryem Gulfem Oner, Kursad Genc & Murat Digicaylioglu. (2011) Intranasal erythropoietin therapy in nervous system disorders. Expert Opinion on Drug Delivery 8:1, pages 19-32.
Read now
Read now
Barbara Luppi, Federica Bigucci, Teresa Cerchiara & Vittorio Zecchi. (2010) Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opinion on Drug Delivery 7:7, pages 811-828.
Read now
Read now
Murat Digicaylioglu. (2010) Erythropoietin in stroke: quo vadis. Expert Opinion on Biological Therapy 10:6, pages 937-949.
Read now
Read now
Mellar P Davis. (2010) Recent development in therapeutics for breakthrough pain. Expert Review of Neurotherapeutics 10:5, pages 757-773.
Read now
Read now
Bin Kong, Yong Sun, Yongjian Li & Dejian Hu. (2009) Preparation and the Influencing Factors of Timozolomide Liposomes. Artificial Cells, Blood Substitutes, and Biotechnology 37:6, pages 279-282.
Read now
Read now
Articles from other publishers (106)
Yuxing Liu & Dawei Wu. (2023) Bi‐directional nasal drug delivery systems: A scoping review of nasal particle deposition patterns and clinical application. Laryngoscope Investigative Otolaryngology.
Crossref
Crossref
Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, Muhammad Jamshaid, Ali Irfan, Gamal A. Shazly, Ana Cláudia Paiva-Santos & Yousef A. Bin Jardan. (2023) Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers. ACS Omega 8:41, pages 38191-38203.
Crossref
Crossref
Garima Rai, Pammi Gauba & Shweta Dang. (2023) Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications. Journal of Drug Delivery Science and Technology 86, pages 104726.
Crossref
Crossref
Mohamed A. Raslan, Sara A. Raslan, Eslam M. Shehata, Amr S. Mahmoud & Nagwa A. Sabri. (2023) Advances in the Applications of Bioinformatics and Chemoinformatics. Pharmaceuticals 16:7, pages 1050.
Crossref
Crossref
Stephen B. Shrewsbury. (2023) The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”. Pharmaceutics 15:6, pages 1720.
Crossref
Crossref
Vinay Kumar & Umesh Gupta. (2023) Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes. Journal of Drug Delivery Science and Technology 84, pages 104466.
Crossref
Crossref
Yang Yao, Yuhuan Jiang, Jialu Song, Ruojing Wang, Zhaoping Li, Lei Yang, Weimin Wu, Luyue Zhang & Qiang Peng. (2022) Exosomes as Potential Functional Nanomaterials for Tissue Engineering. Advanced Healthcare Materials 12:16.
Crossref
Crossref
Anja Haasbroek-Pheiffer, Alvaro Viljoen, Jan Steenekamp, Weiyang Chen & Josias Hamman. (2023) Permeation of Phytochemicals of Selected Psychoactive Medicinal Plants across Excised Sheep Respiratory and Olfactory Epithelial Tissues. Pharmaceutics 15:5, pages 1423.
Crossref
Crossref
Varunesh Sanjay Tambe & Sarika Wairkar. (2023) Lipid-based Nanocarriers via Nose-to-Brain Pathway for Alzheimer's and
Parkinson's Disease. Current Nanoscience 19:3, pages 322-337.
Crossref
Crossref
Wei Qing Lim, Kie Hoon Michelle Luk, Kah Yee Lee, Nasuha Nurul, Sin Jade Loh, Zhen Xiong Yeow, Qi Xuan Wong, Qi Hao Daniel Looi, Pan Pan Chong, Chee Wun How, Sharina Hamzah & Jhi Biau Foo. (2023) Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases. Pharmaceutics 15:4, pages 1216.
Crossref
Crossref
Rinada H Hassan, Heba A Gad, Dalia S Shaker & Rania A H Ishak. (2023) Exploring the potential of intranasal drug delivery systems in the management of hypertension. RPS Pharmacy and Pharmacology Reports 2:2.
Crossref
Crossref
Seung Hwan Son, Na-Rae Lee, Min Sung Gee, Chae Won Song, Soo Jin Lee, Sang-Kyung Lee, Yoonji Lee, Hee Jin Kim, Jong Kil Lee, Kyung-Soo Inn & Nam-Jung Kim. (2023) Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease. ACS Central Science 9:3, pages 417-426.
Crossref
Crossref
Mohammad Sameer Khan, Sradhanjali Mohapatra, Vaibhav Gupta, Ahsan Ali, Punnoth Poonkuzhi Naseef, Mohamed Saheer Kurunian, Abdulkhaliq Ali F. Alshadidi, Md Shamsher Alam, Mohd. Aamir Mirza & Zeenat Iqbal. (2023) Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier. Membranes 13:3, pages 343.
Crossref
Crossref
Bettina Gabold, Friederike Adams, Sophie Brameyer, Kirsten Jung, Christian L. Ried, Thomas Merdan & Olivia M. Merkel. (2022) Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Delivery and Translational Research 13:3, pages 822-838.
Crossref
Crossref
Nidhi Goswami, Mohd Aleem & Kailash Manda. (2022)
Intranasal (
2R, 6R
)‐hydroxynorketamine for acute pain: Behavioural and neurophysiological safety analysis in mice
. Clinical and Experimental Pharmacology and Physiology 50:2, pages 169-177.
Crossref
Crossref
Richard Nii Lante Lamptey, Chengwen Sun, Buddhadev Layek & Jagdish Singh. (2023) Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics. International Journal of Molecular Sciences 24:3, pages 2213.
Crossref
Crossref
Shiv Bahadur & Anubhav Prakash. (2023) A Comprehensive Review on Nanomedicine: Promising Approach for
Treatment of Brain Tumor through Intranasal Administration. Current Drug Targets 24:1, pages 71-88.
Crossref
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
255
297
.
Jéssica Bassi da Silva, Maria Vitoria Gouveia Botan & Marcos Luciano Bruschi. 2023. Nasal Drug Delivery. Nasal Drug Delivery
43
58
.
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery
339
360
.
Nishit Pathak, Sunil K. Vimal, Cao Hongyi & Sanjib Bhattacharya. 2022. Targeted Drug Delivery. Targeted Drug Delivery
389
424
.
Víctor López-Ramis, Susana Canfrán & Ignacio A. Gómez de Segura. (2022) Comparison of the sedative effects of intranasal or intramuscular dexmedetomidine at low doses in healthy dogs: a randomized clinical trial. Veterinary Anaesthesia and Analgesia 49:6, pages 572-579.
Crossref
Crossref
Zhiyu Jin, Yu Han, Danshen Zhang, Zhongqiu Li, Yongshuai Jing, Beibei Hu & Shiguo Sun. (2022) Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 14:10, pages 2070.
Crossref
Crossref
William M. Pardridge. (2022) A Historical Review of Brain Drug Delivery. Pharmaceutics 14:6, pages 1283.
Crossref
Crossref
Di Chen, Jiaying Li, Yichen Huang, Pengju Wei, Wanying Miao, Yaomei Yang & Yanqin Gao. (2022) Interleukin 13 promotes long-term recovery after ischemic stroke by inhibiting the activation of STAT3. Journal of Neuroinflammation 19:1.
Crossref
Crossref
Savvas Dimiou, Rui M. Lopes, Ilona Kubajewska, Ryan D. Mellor, Corinna S. Schlosser, Manjunath S. Shet, Hugh Huang, Ozgur Akcan, Garth T. Whiteside, Andreas G. Schätzlein & Ijeoma F. Uchegbu. (2022) Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. International Journal of Pharmaceutics 618, pages 121658.
Crossref
Crossref
Mireya L. Borrajo & María José Alonso. (2021) Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA. Drug Delivery and Translational Research 12:4, pages 862-880.
Crossref
Crossref
Lea-Adriana Keller, Olivia Merkel & Andreas Popp. (2021) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Delivery and Translational Research 12:4, pages 735-757.
Crossref
Crossref
Tyler P. Crowe & Walter H. Hsu. (2022) Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System. Pharmaceutics 14:3, pages 629.
Crossref
Crossref
Tarek Zieneldien, Janice Kim & Chuanhai Cao. (2022) The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment. Geriatrics 7:2, pages 24.
Crossref
Crossref
Victoria Wolf, Yasir Abdul & Adviye Ergul. (2022) Novel Targets and Interventions for Cognitive Complications of Diabetes. Frontiers in Physiology 12.
Crossref
Crossref
Harsha Jain, Harshita Dalvi, Aditi Bhat, Aashruti Agrawal, Jitender Madan, Pankaj Kumar Singh, Neelesh Kumar Mehra, Shashi Bala Singh & Saurabh Srivastava. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
379
400
.
Marie J. Pauwels, Charysse Vandendriessche & Roosmarijn E. Vandenbroucke. (2021) Special delEVery: Extracellular Vesicles as Promising Delivery Platform to the Brain. Biomedicines 9:11, pages 1734.
Crossref
Crossref
Natalia N. Porfiryeva, Irina I. Semina, Ilgiz A. Salakhov, Rouslan I. Moustafine & Vitaliy V. Khutoryanskiy. (2021) Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 37, pages 102432.
Crossref
Crossref
Adryana Rocha Clementino, Cinzia Marchi, Michele Pozzoli, Franco Bernini, Francesca Zimetti & Fabio Sonvico. (2021) Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases. Frontiers in Pharmacology 12.
Crossref
Crossref
Nasr A. Emad, Bakr Ahmed, Abdulsalam Alhalmi, Nafaa Alzobaidi & Sana Saleh Al-Kubati. (2021) Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 64, pages 102642.
Crossref
Crossref
Shu Li, Chen Guo, Xingjiao Zhang, Xiaojing Liu, Jing Mu, Chunxia Liu, Yali Peng & Min Chang. (2021) Self-assembling modified neuropeptide S enhances nose-to-brain penetration and exerts a prolonged anxiolytic-like effect. Biomaterials Science 9:13, pages 4765-4777.
Crossref
Crossref
Roberta Cassano, Camilla Servidio & Sonia Trombino. (2021) Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases. Materials 14:7, pages 1802.
Crossref
Crossref
Leonor C. Fonseca, João A. Lopes, João Vieira, Cláudia Viegas, Cláudia S. Oliveira, Rafael P. Hartmann & Pedro Fonte. (2021) Intranasal drug delivery for treatment of Alzheimer’s disease. Drug Delivery and Translational Research 11:2, pages 411-425.
Crossref
Crossref
Smrithi Padmakumar, Gregory Jones, Grishma Pawar, Olga Khorkova, Jane Hsiao, Jonghan Kim, Mansoor M. Amiji & Benjamin S. Bleier. (2021) Minimally Invasive Nasal Depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain. Journal of Controlled Release 331, pages 176-186.
Crossref
Crossref
Navid Rabiee, Sepideh Ahmadi, Ronak Afshari, Samira Khalaji, Mohammad Rabiee, Mojtaba Bagherzadeh, Yousef Fatahi, Rassoul Dinarvand, Mohammadreza Tahriri, Lobat Tayebi, Michael R. Hamblin & Thomas J. Webster. (2020) Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease. Advanced Therapeutics 4:3.
Crossref
Crossref
Rizwana Khatoon, Md Aftab Alam & Pramod Kumar Sharma. (2021) Current approaches and prospective drug targeting to brain. Journal of Drug Delivery Science and Technology 61, pages 102098.
Crossref
Crossref
Noha Nafee, Abd El Rahman Ameen & Osama Y. Abdallah. (2020) Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats. AAPS PharmSciTech 22:1.
Crossref
Crossref
Sanjay B. Patil. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
267
285
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, Jessica M. Rosenholm & Kamla Pathak. (2020) Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 12:12, pages 1230.
Crossref
Crossref
Anupam Sarma & Malay K. Das. (2020) Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Molecular Biomedicine 1:1.
Crossref
Crossref
Nikesh Shrestha, Saba Khan, Yub Raj Neupane, Shweta Dang, Shadab Md, Usama A. Fahmy, Sabna Kotta, Nabil A. Alhakamy, Sanjula Baboota & Javed Ali. (2020) Tailoring Midazolam-Loaded Chitosan Nanoparticulate Formulation for Enhanced Brain Delivery via Intranasal Route. Polymers 12:11, pages 2589.
Crossref
Crossref
Yu Long, Qiyue Yang, Yan Xiang, Yulu Zhang, Jinyan Wan, Songyu Liu, Nan Li & Wei Peng. (2020) Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion. Pharmacological Research 159, pages 104795.
Crossref
Crossref
Khaled S. Shamarekh, Heba A. Gad, Mahmoud E. Soliman & Omaima A. Sammour. (2020) Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of tacrine: In-vitro and in-vivo assessment. Journal of Drug Delivery Science and Technology 57, pages 101724.
Crossref
Crossref
Yingqian Xu, Lijia Wei & Hui Wang. (2020) Progress and perspectives on nanoplatforms for drug delivery to the brain. Journal of Drug Delivery Science and Technology 57, pages 101636.
Crossref
Crossref
Mahasweta Paul & Raymond Lau. (2020) Potentials and challenges of Levodopa particle formulation for treatment of Parkinson’s disease through intranasal and pulmonary delivery. Advanced Powder Technology 31:6, pages 2357-2365.
Crossref
Crossref
Shiv Bahadur, Nidhi Sachan, Ranjit K. Harwansh & Rohitas Deshmukh. (2020) Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery. Current Pharmaceutical Design 26:12, pages 1331-1344.
Crossref
Crossref
Hussein Akel, Ruba Ismail & Ildikó Csóka. (2020) Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease. European Journal of Pharmaceutics and Biopharmaceutics 148, pages 38-53.
Crossref
Crossref
Yumin Kim, Soyoung Hwang, Roza Khalmuratova, Sunah Kang, Mingyu Lee, Youngjun Song, Jong-Wan Park, Jaehoon Yu, Hyun-Woo Shin & Yan Lee. (2020) α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition. Journal of Controlled Release 317, pages 181-194.
Crossref
Crossref
Parisa Dehghani, Vahid Jahed & Ali Zarrabi. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine
1
23
.
Marco Vinícius Chaud, Alessandra Cândida Rios, Carolina Alves dos Santos, Cecilia Torqueti de Barros, Juliana Ferreira de Souza & Thais Francine Ribeiro Alves. 2020. Nanomycotoxicology. Nanomycotoxicology
449
480
.
Patricia P. Martins, Hugh D.C. Smyth & Zhengrong Cui. (2019) Strategies to facilitate or block nose-to-brain drug delivery. International Journal of Pharmaceutics 570, pages 118635.
Crossref
Crossref
Puja K. Gangurde, Navya Ajitkumar B.Lalit Kumar. (2018) Lamotrigine Lipid Nanoparticles for Effective Treatment of Epilepsy: a Focus on Brain Targeting via Nasal Route. Journal of Pharmaceutical Innovation 14:2, pages 91-111.
Crossref
Crossref
Moran Haim Zada, Michael Kubek, Wahid Khan, Awanish Kumar & Abraham Domb. (2019) Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH). Journal of Controlled Release 295, pages 278-289.
Crossref
Crossref
Pablo Vicente Torres-Ortega, Laura Saludas, Amira Sayed Hanafy, Elisa Garbayo & María José Blanco-Prieto. (2019) Micro- and nanotechnology approaches to improve Parkinson's disease therapy. Journal of Controlled Release 295, pages 201-213.
Crossref
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2019. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy
43
78
.
Yuhua Weng & Yuanyu Huang. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases
181
208
.
Yang Du, Shuying Wang, Fangyuan Li & Daishun Ling. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases
83
114
.
Abdur Rauf Khan, Xiaoye Yang, Manfei Fu & Guangxi Zhai. (2018) Recent progress of drug nanoformulations targeting to brain. Journal of Controlled Release 291, pages 37-64.
Crossref
Crossref
Franciska Erdő, Luca Anna Bors, Dániel Farkas, Ágnes Bajza & Sveinbjörn Gizurarson. (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Research Bulletin 143, pages 155-170.
Crossref
Crossref
Stella Gänger & Katharina Schindowski. (2018) Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics 10:3, pages 116.
Crossref
Crossref
Eleni Samaridou & Maria José Alonso. (2018) Nose-to-brain peptide delivery – The potential of nanotechnology. Bioorganic & Medicinal Chemistry 26:10, pages 2888-2905.
Crossref
Crossref
Micah D. Renicker, Nicholas Cysewski, Samuel Palmer, Dmytro Nakonechnyy, Andrew Keef, Morgan Thomas, Krisztian Magori & David P. Daberkow. (2018) Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress. Frontiers in Behavioral Neuroscience 12.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
D.C. Dorman. 2018. Comprehensive Toxicology. Comprehensive Toxicology
361
375
.
Carlos Javier Baier, Cristina Eugenia Gallegos, Rita Raisman-Vozari & Alejandra Minetti. (2017) Behavioral impairments following repeated intranasal glyphosate-based herbicide administration in mice. Neurotoxicology and Teratology 64, pages 63-72.
Crossref
Crossref
Fatma Elzahraa Abdelrahman, Ibrahim Elsayed, Mary Kamal Gad, Ahmed Hassen Elshafeey & Magdi Ibrahim Mohamed. (2017) Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. International Journal of Pharmaceutics 530:1-2, pages 1-11.
Crossref
Crossref
Ebtsam M. Abdou, Soha M. Kandil & Hala M.F. El Miniawy. (2017) Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. International Journal of Pharmaceutics 529:1-2, pages 667-677.
Crossref
Crossref
Dongfen Yuan, Xiang Yi, Yuling Zhao, Chi-Duen Poon, Kristin M. Bullock, Kim M. Hansen, Therese S. Salameh, Susan A. Farr, William A. Banks & Alexander V. Kabanov. (2017) Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity. Journal of Controlled Release.
Crossref
Crossref
H. Gao & X. Jiang. 2017. Neurotoxicity of Nanomaterials and Nanomedicine. Neurotoxicity of Nanomaterials and Nanomedicine
331
336
.
Zachary N. Warnken, Hugh D.C. Smyth, Alan B. Watts, Steve Weitman, John G. Kuhn & Robert O. WilliamsIIIIII. (2016) Formulation and device design to increase nose to brain drug delivery. Journal of Drug Delivery Science and Technology 35, pages 213-222.
Crossref
Crossref
Michele Pozzoli, Hui Xin Ong, Lucy Morgan, Maria Sukkar, Daniela Traini, Paul M. Young & Fabio Sonvico. (2016) Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products. European Journal of Pharmaceutics and Biopharmaceutics 107, pages 223-233.
Crossref
Crossref
Huile Gao. (2016) Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B 6:4, pages 268-286.
Crossref
Crossref
Daniel Antunes Viegas, Márcio Rodrigues, Joana Francisco, Amílcar Falcão, Gilberto Alves & Adriana O. Santos. (2016) Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method. European Journal of Pharmaceutical Sciences 89, pages 61-72.
Crossref
Crossref
Santosh Shelke, Sadhana Shahi, Kiran Jadhav, Dinesh Dhamecha, Roshan Tiwari & Hemlata Patil. (2016) Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide. Journal of Materials Science: Materials in Medicine 27:6.
Crossref
Crossref
Giovanna Rassu, Elena Soddu, Massimo Cossu, Elisabetta Gavini, Paolo Giunchedi & Alessandro Dalpiaz. (2016) Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review. Journal of Drug Delivery Science and Technology 32, pages 77-87.
Crossref
Crossref
Oihane Gartziandia, Susana Patricia Egusquiaguirre, John Bianco, José Luis Pedraz, Manoli Igartua, Rosa Maria Hernandez, Véronique Préat & Ana Beloqui. (2016) Nanoparticle transport across in vitro olfactory cell monolayers. International Journal of Pharmaceutics 499:1-2, pages 81-89.
Crossref
Crossref
Jiaqiang Xu, Gao Li, Zhuoyi Wang, Luqin Si, Sijie He, Jialing Cai, Jiangeng Huang & Maureen D. Donovan. (2016) The role of L-type amino acid transporters in the uptake of glyphosate across mammalian epithelial tissues. Chemosphere 145, pages 487-494.
Crossref
Crossref
Eng Soon TeohEng Soon Teoh. 2016. Medicinal Orchids of Asia. Medicinal Orchids of Asia
375
440
.
Gert KrugerLuciana Malavolta & Francisco Romero Cabral. 2015. Advances in the Discovery and Development of Peptide Therapeutics. Advances in the Discovery and Development of Peptide Therapeutics
132
146
.
David C. Dorman & Melanie L. Foster. 2014. Manganese in Health and Disease. Manganese in Health and Disease
119
132
.
Virginia Brown & Fang Liu. (2014) Intranasal Delivery of a Peptide with Antidepressant-Like Effect. Neuropsychopharmacology 39:9, pages 2131-2141.
Crossref
Crossref
Lin Liu, Xiangyi Zhang, Wuchao Li, Haozhen Sun, Yan Lou, Xingguo Zhang & Fanzhu Li. (2013) Transferrin receptor antibody-modified α-cobrotoxin-loaded nanoparticles enable drug delivery across the blood–brain barrier by intranasal administration. Journal of Nanoparticle Research 15:11.
Crossref
Crossref
Huile Gao, Zhiqing Pang & Xinguo Jiang. (2013) Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System. Pharmaceutical Research 30:10, pages 2485-2498.
Crossref
Crossref
Katherine E Warren. (2013) Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncology 2:5, pages 427-435.
Crossref
Crossref
Rashmin B. Patel, Mrunali R. Patel, Kashayap K. Bhatt & Bharat G. Patel. (2013) Paliperidone-Loaded Mucoadhesive Microemulsion in Treatment of Schizophrenia: Formulation Consideration. Journal of Pharmaceutical Innovation 8:3, pages 195-204.
Crossref
Crossref
R.B. Patel, M.R. Patel, K.K. Bhatt & B.G. Patel. (2013) Risperidone-Loaded Mucoadhesive Microemulsion for Intranasal Delivery: Formulation Development, Physicochemical Characterization and Ex Vivo Evaluation. Journal of Drug Delivery Science and Technology 23:6, pages 561-567.
Crossref
Crossref
Catherine Campbell, Bruce H MorimotoDaniela Nenciu & Anthony W Fox. (2012) Drug development of intranasally delivered peptides. Therapeutic Delivery 3:4, pages 557-568.
Crossref
Crossref
Dan B. Renner, William H. FreyIIII & Leah R. Hanson. (2012) Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway. Neuroscience Letters 513:2, pages 193-197.
Crossref
Crossref
Hongbing Wu, Jianxu Li, Qizhi Zhang, Xiluan Yan, Liangran Guo, Xiaoling Gao, Mingfeng Qiu, Xinguo Jiang, Ren Lai & Hongzhuan Chen. (2012) A novel small Odorranalectin-bearing cubosomes: Preparation, brain delivery and pharmacodynamic study on amyloid-β25–35-treated rats following intranasal administration. European Journal of Pharmaceutics and Biopharmaceutics 80:2, pages 368-378.
Crossref
Crossref
Douglas E. Hobson. (2012) Asymmetry in parkinsonism, spreading pathogens and the nose. Parkinsonism & Related Disorders 18:1, pages 1-9.
Crossref
Crossref
Rui D. S. Prediger, Aderbal S. AguiarJr.Jr., Filipe C. Matheus, Roger Walz, Layal Antoury, Rita Raisman-Vozari & Richard L. Doty. (2011) Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson’s Disease. Neurotoxicity Research 21:1, pages 90-116.
Crossref
Crossref
Xiaoying Zhuang, Xiaoyu Xiang, William Grizzle, Dongmei Sun, Shuangqin Zhang, Robert C Axtell, Songwen Ju, Jiangyao Mu, Lifeng Zhang, Lawrence Steinman, Donald Miller & Huang-Ge Zhang. (2011) Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain. Molecular Therapy 19:10, pages 1769-1779.
Crossref
Crossref
Luciana Malavolta & Francisco Romero Cabral. (2011) Peptides: Important tools for the treatment of central nervous system disorders. Neuropeptides 45:5, pages 309-316.
Crossref
Crossref
Robert A. Scranton, Lauren Fletcher, Shane Sprague, David F. Jimenez & Murat Digicaylioglu. (2011) The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS. PLoS ONE 6:4, pages e18711.
Crossref
Crossref
C. O. Da Fonseca, Raphael M. Teixeira, Ricardo Ramina, Giovana Kovaleski, Júlio Thome Silva, Janaína Nagel & Thereza Quirico-Santos. (2011) Case of Advanced Recurrent Glioblastoma Successfully Treated with Monoterpene Perillyl Alcohol by Intranasal Administration. Journal of Cancer Therapy 02:01, pages 16-21.
Crossref
Crossref
M. Intakhab Alam, Sarwar Beg, Abdus Samad, Sanjula Baboota, Kanchan Kohli, Javed Ali, Alka Ahuja & M. Akbar. (2010) Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences 40:5, pages 385-403.
Crossref
Crossref
R.I. Henkin. (2010) Intranasal insulin: From nose to brain. Nutrition 26:6, pages 624-633.
Crossref
Crossref
D.C. Dorman. 2010. Comprehensive Toxicology. Comprehensive Toxicology
263
276
.
David J. Brayden, Emilie J. M. Oudot & Alan W. Baird. 2010. Comparative and Veterinary Pharmacology. Comparative and Veterinary Pharmacology
79
112
.